Clinical TrialsSearch results
Number of results: 153
Other
- A phase II study of the remission induction and maintenance therapy by rituximab for rituximab naive low grade B cell lymphoma.
- low grade B cell lymphoma
- Clinical Hematology Study Group of National Hospital Organization(CHSG-NHO)
- 2008-06-20
Other
- Cilostazol trial
- peripheral arterial disease
- Kokura Memorial Hospital
- 2008-06-20
Other
- Randomized phase III study of CPT-11 versus Weekly Paclitaxel for unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum.
- unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum
- West Japan Oncology Group
- 2008-07-15
Other
- Safety and efficacy of preoperative chemotherapy with mFOLFOX6+Bevacizumab in patients with liver-only metastases (H2, H3) from colorectal cancer; histological assessment of liver damage from preoperative chemotherapy.
- Patients with liver-only metastases from colorectal cancer
- Kyushu Study group of Clinical Cancer
- 2008-08-08
Other
- Safety and efficacy of Alternating mFOLFOX6 plus bevacizumab and FOLFIRI plus bevacizumab every 4cycles as First line Therapy in Advanced colorectal Cancer
- Unresectable advanced/recurrent colorectal cancer
- KSCC
- 2008-08-12
Other
- Phase II study of combination therapy with Irinotecan and S-1 in patients with progressive colorectal cancer after FOLFOX regimen
- Unresectable advanced/recurrent colorectal cancer
- KSCC
- 2008-08-29
Other
- The efficacy and feasibility of the repeated intraperitoneal Paclitaxel +systemic TS-1 and Paclitaxel for far advanced or recurrent gastric cancer: Phase I/II trial.
- Far advanced or recurrent gastric cancer
- Department of Surgical Oncology The University of Tokyo
- 2008-08-30
Other
- Safety of Biologics in Clinical Use in Japanese Patients with Rheumatoid Arthritis in Long-Term (SECURE)
- Rheumatoid Arthritis
- Japan College of Rheumatology
- 2008-09-01
Other
- Phase II trial of TS-1 and cisplatin in patients with Carcinoma of Unknown Primary Sites (KMOG 0607)
- Carcinoma of Unknown Primary Sites
- Kyushu Medical Oncology Group
- 2008-09-09
Other
- An Open-Label Randomized Phase III Study of Capecitabine(6 months) versus Capecitabine(12 months) as Adjuvant Chemotherapy for Stage III(Dukes'C) Colon Cancer Patients.
- Colon cancer
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2008-09-10